2.A Case Report of Cutaneous Protothecosis with Severe Pustules and Ulceration.
Sungnack LEE ; Jie Hoon KIM ; Eun So LEE
Korean Journal of Medical Mycology 1999;4(2):131-136
No abstract available.
Ulcer*
3.Retraction: The Clinical Characteristics and Treatment Results of Bilateral Sudden Sensorineural Hearing Loss.
Jeong Hoon OH ; Keehyun PARK ; Seung Joo LEE ; Jie Soo KIM ; Yun Hoon CHOUNG
Korean Journal of Otolaryngology - Head and Neck Surgery 2011;54(1):107-107
No abstract available.
4.Retraction: The Effects of Intratympanic Steroid Injection for the Patients with Refractory Sudden Sensorineural Hearing Loss.
Yun Hoon CHOUNG ; Keehyun PARK ; Jung Yun MO ; Jeong Hoon OH ; Jie Soo KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2011;54(1):106-106
No abstract available.
5.The Clinical Characteristics and Treatment Results of Bilateral Sudden Sensorineural Hearing Loss.
Jeong Hoon OH ; Keehyun PARK ; Seung Joo LEE ; Jie Soo KIM ; Yun Hoon CHOUNG
Korean Journal of Otolaryngology - Head and Neck Surgery 2005;48(7):848-853
BACKGROUND AND OBJECTIVES: Most cases of sudden deafness remain idiopathic. The majority of these cases are unilateral in their occurrences, whereas bilateral simultaneous involvement is rarely seen. We analyzed the clinical characteristics and treatment results between bilateral and unilateral sudden sensorineural hearing loss (SSNHL), and considered the possible causes and provided available data for planning the appropriate treatment for bilateral SSNHL. SUBJECTS AND METHOD: Three hundred forty seven patients who visited the Department of Otolaryngology in Ajou University Hospital from June, 1994 to February, 2003 were classified into 3 groups. Of these 347 patients, 16 patients (32 ears) had SSNHL simultaneously in both ears (Group I), 23 patients had SSNHL sequentially in both ears (Group II), and 308 patients had unilateral SSNHL (Group III). We reviewed their charts for pure tone audiometry information, medical history and lipid panel information to compare bilateral SSNHL with unilateral SSNHL. RESULTS: The incidence of simultaneous bilateral SSNHL (Group I) was 4.6% of overall patients with SSNHL. Bilateral SSNHL occurs more commonly in patients of older age, with preexisting DM. Lpid panel abnormalities were compared with unilateral SSNHL. The recovery rate of hearing in simultaneous bilateral SSNHL (Group I) was 37.5% for both ears and 62.5% of patients, compared with 56.5% in unilateral SSNHL (Group III). CONCLUSION: Bilateral SSNHL is a very rare disease and the outcome from treatment is important for patients' quality of life. Recognition of similarities and differences between bilateral and unilateral SSNHL can help in counseling and managing the patients.
Audiometry
;
Counseling
;
Ear
;
Hearing
;
Hearing Loss, Sensorineural*
;
Hearing Loss, Sudden
;
Humans
;
Incidence
;
Otolaryngology
;
Quality of Life
;
Rare Diseases
6.The Effects of Intratympanic Steroid Injection for the Patients with Refractory Sudden Sensorineural Hearing Loss.
Yun Hoon CHOUNG ; Keehyun PARK ; Jung Yun MO ; Jeong Hoon OH ; Jie Soo KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2005;48(6):706-712
BACKGROUND AND OBJECTIVES: High-dose steroid therapy has been known as the treatment of choice for sudden sensorineural hearing loss (SSNHL). However, about one third of patients do not generally respond to any treatments, and there seem to be no definitive treatment for the patients with refractory SSNHL. We prospectively studied the effect of intratympanic steroid injection (ITSI) for patients with refractory SSNHL. SUBJECTS AND METHOD: Sixty six patients with SSNHL, who were refractory to a course of oral steroid therapy, were included in this study. Thirty three patients (34 ears) were treated with ITSI and the other 33 patients had no further treatments as control. ITSI was performed with dexamethasone in the supine position on 4 separate occasions over the course of 2 weeks. Hearing was assessed immediately before every injection, and at 1 and 4 weeks after therapy. Hearing improvement was defined as more than 10 dB in pure tone average (PTA). RESULTS: Hearing improvement was observed in 13 (39.4%) of 33 patients who underwent ITSI and in 2 (6.1%) of 33 patients in control group. Five of 13 showed hearing improvement over 20 dB in PTA, and 11 of 20 patients showed no improvement in PTA by ITSI, but showed improvement over 10dB in some frequencies. There were no definite prognostic factors between the patients who responded to ITSI and those who didn't. CONCLUSION: ITSI is a simple and effective therapy for patients with refractory SSNHL.
Dexamethasone
;
Ear, Middle
;
Hearing
;
Hearing Loss, Sensorineural*
;
Hearing Loss, Sudden
;
Humans
;
Prospective Studies
;
Steroids
;
Supine Position
7.Secondary cutaneous amyloidosis in disseminated superficial porokeratosis: a case report.
Jie Hoon KIM ; Hyun ee YIM ; Won Hyoung KANG
Journal of Korean Medical Science 2000;15(4):478-481
Disseminated superficial porokeratosis (DSP) is a rare cause of secondary cutaneous amyloidosis. An 83-year-old male patient showed an increase in both size and number of DSP lesions after contracting pulmonary tuberculosis. The DSP lesions of the patient consisted of numerous annular eruptions on both sun-exposed and sun-protected areas, which occurred over a period of 20 years. Multiple skin biopsies were taken from normal or lesional/sun-exposed or sun-protected skin samples. Histopathologic examination included routine H+ACY-E stains, Congo red stains, thioflavin-T stains and anticytokeratin antibodies (AE1, AE3). And the results were as follows+ADs- 1) Positive staining with Congo red and thioflavin-T indicated an amyloid nature for the deposits, 2) confinement of the amyloid deposition just below the lesional epidermis (while sparing the neighboring uninvolved or distant normal skin) indicated some role of the lesional epidermis, and 3) positive staining with AE3 further indicated an epidermal origin-type II epithelial keratin-of the amyloid. We present a case of DSP with a local amyloid deposit, characterized by association of positive familial background, severe pruritus and pulmonary tuberculosis.
Aged
;
Aged, 80 and over
;
Amyloid/analysis
;
Amyloidosis/etiology+ACo-
;
Case Report
;
Congo Red
;
Dyes
;
Epidermis/chemistry
;
Human
;
Male
;
Porokeratosis/complications+ACo-
;
Pruritus/etiology
;
Skin Diseases/etiology+ACo-
;
Staining and Labeling
;
Thiazoles
;
Tuberculosis, Pulmonary/complications
8.Secondary cutaneous amyloidosis in disseminated superficial porokeratosis: a case report.
Jie Hoon KIM ; Hyun ee YIM ; Won Hyoung KANG
Journal of Korean Medical Science 2000;15(4):478-481
Disseminated superficial porokeratosis (DSP) is a rare cause of secondary cutaneous amyloidosis. An 83-year-old male patient showed an increase in both size and number of DSP lesions after contracting pulmonary tuberculosis. The DSP lesions of the patient consisted of numerous annular eruptions on both sun-exposed and sun-protected areas, which occurred over a period of 20 years. Multiple skin biopsies were taken from normal or lesional/sun-exposed or sun-protected skin samples. Histopathologic examination included routine H+ACY-E stains, Congo red stains, thioflavin-T stains and anticytokeratin antibodies (AE1, AE3). And the results were as follows+ADs- 1) Positive staining with Congo red and thioflavin-T indicated an amyloid nature for the deposits, 2) confinement of the amyloid deposition just below the lesional epidermis (while sparing the neighboring uninvolved or distant normal skin) indicated some role of the lesional epidermis, and 3) positive staining with AE3 further indicated an epidermal origin-type II epithelial keratin-of the amyloid. We present a case of DSP with a local amyloid deposit, characterized by association of positive familial background, severe pruritus and pulmonary tuberculosis.
Aged
;
Aged, 80 and over
;
Amyloid/analysis
;
Amyloidosis/etiology+ACo-
;
Case Report
;
Congo Red
;
Dyes
;
Epidermis/chemistry
;
Human
;
Male
;
Porokeratosis/complications+ACo-
;
Pruritus/etiology
;
Skin Diseases/etiology+ACo-
;
Staining and Labeling
;
Thiazoles
;
Tuberculosis, Pulmonary/complications
9.Peri-operative Inflammatory Marker as a Predictive Factor for Prolonged Post-operative Ileus After Gastrectomy for Gastric Cancer
Yonsoo KIM ; Young Min KIM ; Jie-Hyun KIM ; Young Hoon YOUN ; Jong Won KIM ; Hyojin PARK
Journal of Neurogastroenterology and Motility 2021;27(4):588-595
Background/Aims:
Although prolonged post-operative ileus (PPOI) is an important factor for the prolonged length of post-operative hospital stay, there is still a lack of effective predictive and therapeutic methods for PPOI. Previous studies reported that increased inflammatory markers, such as C-reactive protein (CRP) level and neutrophil to lymphocyte ratio (NLR), are associated with malignancies. The aim of our study is to elucidate the association between peri-operative inflammatory markers and PPOI after gastrectomy for gastric cancer.
Methods:
We enrolled patients who received gastrectomy for gastric cancer from June 2013 to January 2016 at a single tertiary referral center in Seoul, Korea. We evaluated peri-operative inflammatory markers, including CRP level, NLR, and platelet to lymphocyte ratio (PLR) of enrolled patients. We compared these data between control group and PPOI group.
Results:
A total of 390 subjects were enrolled in this study, and 132 patients (33.8%) showed PPOI. In univariate analysis, preoperative CRP level and NLR, post-operative day (POD) 1 CRP level, NLR, and PLR, and POD3 CRP level, NLR, and PLR were significantly associated with PPOI. In multivariate analysis, preoperative NLR (P = 0.014), POD1 NLR (P = 0.019), POD3 CRP (P = 0.004), and POD3 NLR (P = 0.008) were independent risk factors for PPOI.
Conclusions
Peri-operative inflammatory markers, such as CRP level and NLR, are useful predictive factors for PPOI who received gastrectomy for gastric cancer. Moreover, prophylactic antibiotics and anti-inflammatory drugs can be preventive and therapeutic agents for PPOI.
10.Peri-operative Inflammatory Marker as a Predictive Factor for Prolonged Post-operative Ileus After Gastrectomy for Gastric Cancer
Yonsoo KIM ; Young Min KIM ; Jie-Hyun KIM ; Young Hoon YOUN ; Jong Won KIM ; Hyojin PARK
Journal of Neurogastroenterology and Motility 2021;27(4):588-595
Background/Aims:
Although prolonged post-operative ileus (PPOI) is an important factor for the prolonged length of post-operative hospital stay, there is still a lack of effective predictive and therapeutic methods for PPOI. Previous studies reported that increased inflammatory markers, such as C-reactive protein (CRP) level and neutrophil to lymphocyte ratio (NLR), are associated with malignancies. The aim of our study is to elucidate the association between peri-operative inflammatory markers and PPOI after gastrectomy for gastric cancer.
Methods:
We enrolled patients who received gastrectomy for gastric cancer from June 2013 to January 2016 at a single tertiary referral center in Seoul, Korea. We evaluated peri-operative inflammatory markers, including CRP level, NLR, and platelet to lymphocyte ratio (PLR) of enrolled patients. We compared these data between control group and PPOI group.
Results:
A total of 390 subjects were enrolled in this study, and 132 patients (33.8%) showed PPOI. In univariate analysis, preoperative CRP level and NLR, post-operative day (POD) 1 CRP level, NLR, and PLR, and POD3 CRP level, NLR, and PLR were significantly associated with PPOI. In multivariate analysis, preoperative NLR (P = 0.014), POD1 NLR (P = 0.019), POD3 CRP (P = 0.004), and POD3 NLR (P = 0.008) were independent risk factors for PPOI.
Conclusions
Peri-operative inflammatory markers, such as CRP level and NLR, are useful predictive factors for PPOI who received gastrectomy for gastric cancer. Moreover, prophylactic antibiotics and anti-inflammatory drugs can be preventive and therapeutic agents for PPOI.